Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.60
+1.3%
$7.95
$3.44
$37.00
$55M15.96 million shs192,445 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$306.87
-1.6%
$305.70
$273.71
$559.95
$70.20B0.591.99 million shs2.00 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$63.80
-1.0%
$66.42
$51.90
$84.39
$14.33B0.571.33 million shs1.28 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$100.11
-1.2%
$109.19
$99.73
$146.36
$3.55B1.03289,350 shs654,541 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
0.00%-95.75%-95.27%-93.48%-98.94%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.00%-0.65%+0.93%-17.23%-43.41%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%-3.46%-4.96%-1.12%-20.58%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%-4.95%-4.97%-14.30%-19.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.60
+1.3%
$7.95
$3.44
$37.00
$55M15.96 million shs192,445 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$306.87
-1.6%
$305.70
$273.71
$559.95
$70.20B0.591.99 million shs2.00 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$63.80
-1.0%
$66.42
$51.90
$84.39
$14.33B0.571.33 million shs1.28 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$100.11
-1.2%
$109.19
$99.73
$146.36
$3.55B1.03289,350 shs654,541 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
0.00%-95.75%-95.27%-93.48%-98.94%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.00%-0.65%+0.93%-17.23%-43.41%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%-3.46%-4.96%-1.12%-20.58%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%-4.95%-4.97%-14.30%-19.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$35.00360.53% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.67
Moderate Buy$411.0633.95% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.59
Moderate Buy$78.0022.26% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
3.00
Buy$140.2540.10% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and HOLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/5/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$435.00 ➝ $425.00
9/4/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$327.00 ➝ $373.00
8/18/2025
Hologic, Inc. stock logo
HOLX
Hologic
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldBuy$80.00
8/15/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$400.00 ➝ $330.00
8/6/2025
Hologic, Inc. stock logo
HOLX
Hologic
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSector PerformOutperform$72.00 ➝ $87.00
7/31/2025
Hologic, Inc. stock logo
HOLX
Hologic
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$75.00
7/31/2025
Hologic, Inc. stock logo
HOLX
Hologic
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$65.00 ➝ $69.00
7/31/2025
Hologic, Inc. stock logo
HOLX
Hologic
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$65.00 ➝ $70.00
7/25/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$492.00 ➝ $297.00
7/25/2025
Integer Holdings Corporation stock logo
ITGR
Integer
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$150.00 ➝ $143.00
7/25/2025
Integer Holdings Corporation stock logo
ITGR
Integer
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$145.00 ➝ $137.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$71.32M15.63N/AN/A$0.14 per share54.29
Elevance Health, Inc. stock logo
ELV
Elevance Health
$177.01B0.39$38.55 per share7.96$178.62 per share1.72
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.52$5.44 per share11.72$22.09 per share2.89
Integer Holdings Corporation stock logo
ITGR
Integer
$1.72B2.04$8.80 per share11.38$48.27 per share2.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$0.29N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$23.5013.067.861.142.83%17.59%6.36%10/16/2025 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.4126.4713.812.3413.79%19.69%10.82%11/3/2025 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$119.90M$2.2744.1015.050.804.61%12.27%6.23%10/23/2025 (Estimated)

Latest ITGR, BDSX, ELV, and HOLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$1.40-$1.60-$0.20-$0.08$18.47 million$20.02 million
7/30/2025Q3 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.05$1.08+$0.03$0.86$1.01 billion$1.02 billion
7/24/2025Q2 2025
Integer Holdings Corporation stock logo
ITGR
Integer
$1.57$1.55-$0.02$1.04$464.37 million$476.00 million
7/17/2025Q2 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$9.30$8.84-$0.46$7.72$48.26 billion$49.42 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.842.23%N/A29.11%14 Years
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A

Latest ITGR, BDSX, ELV, and HOLX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/17/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.712.23%9/10/20259/10/20259/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
41.11
2.14
2.14
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.64
1.44
1.44
Hologic, Inc. stock logo
HOLX
Hologic
0.52
3.55
2.81
Integer Holdings Corporation stock logo
ITGR
Integer
0.72
3.41
2.18

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Integer Holdings Corporation stock logo
ITGR
Integer
2.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
220146.63 million102.50 millionOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,200225.18 million224.53 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.42 million218.24 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00035.03 million34.28 millionOptionable

Recent News About These Companies

Integer (NYSE:ITGR) Sets New 12-Month Low - What's Next?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biodesix stock logo

Biodesix NASDAQ:BDSX

$7.60 +0.10 (+1.31%)
Closing price 04:00 PM Eastern
Extended Trading
$7.57 -0.03 (-0.38%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Elevance Health stock logo

Elevance Health NYSE:ELV

$306.87 -4.89 (-1.57%)
Closing price 03:59 PM Eastern
Extended Trading
$307.94 +1.07 (+0.35%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Hologic stock logo

Hologic NASDAQ:HOLX

$63.80 -0.65 (-1.01%)
Closing price 04:00 PM Eastern
Extended Trading
$63.76 -0.04 (-0.06%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$100.11 -1.23 (-1.21%)
Closing price 03:59 PM Eastern
Extended Trading
$100.04 -0.07 (-0.07%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.